0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Clinical Trial Material Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-25E14890
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Clinical Trial Material Market Insights Forecast to 2029
BUY CHAPTERS

Global Clinical Trial Material Market Research Report 2024

Code: QYRE-Auto-25E14890
Report
April 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Clinical Trial Material Market

Clinical Trial Material means any raw materials, parts, or supplies used in the ordinary course of development of a Product for which regulatory approval has not yet been obtained and that are used exclusively for purposes of supporting clinical and preclinical research.
The global Clinical Trial Material market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Clinical Trial Material is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Clinical Trial Material is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Clinical Trial Material in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Clinical Trial Material include Thermo Fisher Scientific, Marken, Catalent, Eurofins Scientific, Biocair, Almac Group, Piramal Pharma Solutions, Parexel and PRA Health Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Material, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Material.

Report Scope

The Clinical Trial Material market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Trial Material market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial Material companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Clinical Trial Material Market Report

Report Metric Details
Report Name Clinical Trial Material Market
Segment by Type
  • Small-molecules
  • Biologic Drugs
  • Medical Devices
Segment by Application
  • Oncology
  • CNS
  • Cardiovascular Diseases
  • Digestive Disorders
  • Immunology
  • Blood Disorders
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Marken, Catalent, Eurofins Scientific, Biocair, Almac Group, Piramal Pharma Solutions, Parexel, PRA Health Sciences, PCI Pharma Services, Capsugel, OCT Group, Acnos Pharma, KLIFO, Ancillare, LP, ADAllen Pharma, Recipharm, Movianto
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Clinical Trial Material companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Clinical Trial Material Market report?

Ans: The main players in the Clinical Trial Material Market are Thermo Fisher Scientific, Marken, Catalent, Eurofins Scientific, Biocair, Almac Group, Piramal Pharma Solutions, Parexel, PRA Health Sciences, PCI Pharma Services, Capsugel, OCT Group, Acnos Pharma, KLIFO, Ancillare, LP, ADAllen Pharma, Recipharm, Movianto

What are the Application segmentation covered in the Clinical Trial Material Market report?

Ans: The Applications covered in the Clinical Trial Material Market report are Oncology, CNS, Cardiovascular Diseases, Digestive Disorders, Immunology, Blood Disorders, Other

What are the Type segmentation covered in the Clinical Trial Material Market report?

Ans: The Types covered in the Clinical Trial Material Market report are Small-molecules, Biologic Drugs, Medical Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trial Material Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Small-molecules
1.2.3 Biologic Drugs
1.2.4 Medical Devices
1.3 Market by Application
1.3.1 Global Clinical Trial Material Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 CNS
1.3.4 Cardiovascular Diseases
1.3.5 Digestive Disorders
1.3.6 Immunology
1.3.7 Blood Disorders
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial Material Market Perspective (2019-2030)
2.2 Clinical Trial Material Growth Trends by Region
2.2.1 Global Clinical Trial Material Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Clinical Trial Material Historic Market Size by Region (2019-2024)
2.2.3 Clinical Trial Material Forecasted Market Size by Region (2025-2030)
2.3 Clinical Trial Material Market Dynamics
2.3.1 Clinical Trial Material Industry Trends
2.3.2 Clinical Trial Material Market Drivers
2.3.3 Clinical Trial Material Market Challenges
2.3.4 Clinical Trial Material Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trial Material Players by Revenue
3.1.1 Global Top Clinical Trial Material Players by Revenue (2019-2024)
3.1.2 Global Clinical Trial Material Revenue Market Share by Players (2019-2024)
3.2 Global Clinical Trial Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Trial Material Revenue
3.4 Global Clinical Trial Material Market Concentration Ratio
3.4.1 Global Clinical Trial Material Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Material Revenue in 2023
3.5 Clinical Trial Material Key Players Head office and Area Served
3.6 Key Players Clinical Trial Material Product Solution and Service
3.7 Date of Enter into Clinical Trial Material Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Material Breakdown Data by Type
4.1 Global Clinical Trial Material Historic Market Size by Type (2019-2024)
4.2 Global Clinical Trial Material Forecasted Market Size by Type (2025-2030)
5 Clinical Trial Material Breakdown Data by Application
5.1 Global Clinical Trial Material Historic Market Size by Application (2019-2024)
5.2 Global Clinical Trial Material Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Clinical Trial Material Market Size (2019-2030)
6.2 North America Clinical Trial Material Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Clinical Trial Material Market Size by Country (2019-2024)
6.4 North America Clinical Trial Material Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trial Material Market Size (2019-2030)
7.2 Europe Clinical Trial Material Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Clinical Trial Material Market Size by Country (2019-2024)
7.4 Europe Clinical Trial Material Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Material Market Size (2019-2030)
8.2 Asia-Pacific Clinical Trial Material Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Clinical Trial Material Market Size by Region (2019-2024)
8.4 Asia-Pacific Clinical Trial Material Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Trial Material Market Size (2019-2030)
9.2 Latin America Clinical Trial Material Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Clinical Trial Material Market Size by Country (2019-2024)
9.4 Latin America Clinical Trial Material Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial Material Market Size (2019-2030)
10.2 Middle East & Africa Clinical Trial Material Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Clinical Trial Material Market Size by Country (2019-2024)
10.4 Middle East & Africa Clinical Trial Material Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Clinical Trial Material Introduction
11.1.4 Thermo Fisher Scientific Revenue in Clinical Trial Material Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Marken
11.2.1 Marken Company Detail
11.2.2 Marken Business Overview
11.2.3 Marken Clinical Trial Material Introduction
11.2.4 Marken Revenue in Clinical Trial Material Business (2019-2024)
11.2.5 Marken Recent Development
11.3 Catalent
11.3.1 Catalent Company Detail
11.3.2 Catalent Business Overview
11.3.3 Catalent Clinical Trial Material Introduction
11.3.4 Catalent Revenue in Clinical Trial Material Business (2019-2024)
11.3.5 Catalent Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Detail
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Clinical Trial Material Introduction
11.4.4 Eurofins Scientific Revenue in Clinical Trial Material Business (2019-2024)
11.4.5 Eurofins Scientific Recent Development
11.5 Biocair
11.5.1 Biocair Company Detail
11.5.2 Biocair Business Overview
11.5.3 Biocair Clinical Trial Material Introduction
11.5.4 Biocair Revenue in Clinical Trial Material Business (2019-2024)
11.5.5 Biocair Recent Development
11.6 Almac Group
11.6.1 Almac Group Company Detail
11.6.2 Almac Group Business Overview
11.6.3 Almac Group Clinical Trial Material Introduction
11.6.4 Almac Group Revenue in Clinical Trial Material Business (2019-2024)
11.6.5 Almac Group Recent Development
11.7 Piramal Pharma Solutions
11.7.1 Piramal Pharma Solutions Company Detail
11.7.2 Piramal Pharma Solutions Business Overview
11.7.3 Piramal Pharma Solutions Clinical Trial Material Introduction
11.7.4 Piramal Pharma Solutions Revenue in Clinical Trial Material Business (2019-2024)
11.7.5 Piramal Pharma Solutions Recent Development
11.8 Parexel
11.8.1 Parexel Company Detail
11.8.2 Parexel Business Overview
11.8.3 Parexel Clinical Trial Material Introduction
11.8.4 Parexel Revenue in Clinical Trial Material Business (2019-2024)
11.8.5 Parexel Recent Development
11.9 PRA Health Sciences
11.9.1 PRA Health Sciences Company Detail
11.9.2 PRA Health Sciences Business Overview
11.9.3 PRA Health Sciences Clinical Trial Material Introduction
11.9.4 PRA Health Sciences Revenue in Clinical Trial Material Business (2019-2024)
11.9.5 PRA Health Sciences Recent Development
11.10 PCI Pharma Services
11.10.1 PCI Pharma Services Company Detail
11.10.2 PCI Pharma Services Business Overview
11.10.3 PCI Pharma Services Clinical Trial Material Introduction
11.10.4 PCI Pharma Services Revenue in Clinical Trial Material Business (2019-2024)
11.10.5 PCI Pharma Services Recent Development
11.11 Capsugel
11.11.1 Capsugel Company Detail
11.11.2 Capsugel Business Overview
11.11.3 Capsugel Clinical Trial Material Introduction
11.11.4 Capsugel Revenue in Clinical Trial Material Business (2019-2024)
11.11.5 Capsugel Recent Development
11.12 OCT Group
11.12.1 OCT Group Company Detail
11.12.2 OCT Group Business Overview
11.12.3 OCT Group Clinical Trial Material Introduction
11.12.4 OCT Group Revenue in Clinical Trial Material Business (2019-2024)
11.12.5 OCT Group Recent Development
11.13 Acnos Pharma
11.13.1 Acnos Pharma Company Detail
11.13.2 Acnos Pharma Business Overview
11.13.3 Acnos Pharma Clinical Trial Material Introduction
11.13.4 Acnos Pharma Revenue in Clinical Trial Material Business (2019-2024)
11.13.5 Acnos Pharma Recent Development
11.14 KLIFO
11.14.1 KLIFO Company Detail
11.14.2 KLIFO Business Overview
11.14.3 KLIFO Clinical Trial Material Introduction
11.14.4 KLIFO Revenue in Clinical Trial Material Business (2019-2024)
11.14.5 KLIFO Recent Development
11.15 Ancillare, LP
11.15.1 Ancillare, LP Company Detail
11.15.2 Ancillare, LP Business Overview
11.15.3 Ancillare, LP Clinical Trial Material Introduction
11.15.4 Ancillare, LP Revenue in Clinical Trial Material Business (2019-2024)
11.15.5 Ancillare, LP Recent Development
11.16 ADAllen Pharma
11.16.1 ADAllen Pharma Company Detail
11.16.2 ADAllen Pharma Business Overview
11.16.3 ADAllen Pharma Clinical Trial Material Introduction
11.16.4 ADAllen Pharma Revenue in Clinical Trial Material Business (2019-2024)
11.16.5 ADAllen Pharma Recent Development
11.17 Recipharm
11.17.1 Recipharm Company Detail
11.17.2 Recipharm Business Overview
11.17.3 Recipharm Clinical Trial Material Introduction
11.17.4 Recipharm Revenue in Clinical Trial Material Business (2019-2024)
11.17.5 Recipharm Recent Development
11.18 Movianto
11.18.1 Movianto Company Detail
11.18.2 Movianto Business Overview
11.18.3 Movianto Clinical Trial Material Introduction
11.18.4 Movianto Revenue in Clinical Trial Material Business (2019-2024)
11.18.5 Movianto Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Clinical Trial Material Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Small-molecules
    Table 3. Key Players of Biologic Drugs
    Table 4. Key Players of Medical Devices
    Table 5. Global Clinical Trial Material Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Clinical Trial Material Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Clinical Trial Material Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Clinical Trial Material Market Share by Region (2019-2024)
    Table 9. Global Clinical Trial Material Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Clinical Trial Material Market Share by Region (2025-2030)
    Table 11. Clinical Trial Material Market Trends
    Table 12. Clinical Trial Material Market Drivers
    Table 13. Clinical Trial Material Market Challenges
    Table 14. Clinical Trial Material Market Restraints
    Table 15. Global Clinical Trial Material Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Clinical Trial Material Market Share by Players (2019-2024)
    Table 17. Global Top Clinical Trial Material Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Material as of 2023)
    Table 18. Ranking of Global Top Clinical Trial Material Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Clinical Trial Material Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Clinical Trial Material Product Solution and Service
    Table 22. Date of Enter into Clinical Trial Material Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Clinical Trial Material Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Clinical Trial Material Revenue Market Share by Type (2019-2024)
    Table 26. Global Clinical Trial Material Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Clinical Trial Material Revenue Market Share by Type (2025-2030)
    Table 28. Global Clinical Trial Material Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Clinical Trial Material Revenue Market Share by Application (2019-2024)
    Table 30. Global Clinical Trial Material Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Clinical Trial Material Revenue Market Share by Application (2025-2030)
    Table 32. North America Clinical Trial Material Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Clinical Trial Material Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Clinical Trial Material Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Clinical Trial Material Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Clinical Trial Material Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Clinical Trial Material Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Clinical Trial Material Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Clinical Trial Material Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Clinical Trial Material Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Clinical Trial Material Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Clinical Trial Material Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Clinical Trial Material Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Clinical Trial Material Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Clinical Trial Material Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Clinical Trial Material Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Thermo Fisher Scientific Company Detail
    Table 48. Thermo Fisher Scientific Business Overview
    Table 49. Thermo Fisher Scientific Clinical Trial Material Product
    Table 50. Thermo Fisher Scientific Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 51. Thermo Fisher Scientific Recent Development
    Table 52. Marken Company Detail
    Table 53. Marken Business Overview
    Table 54. Marken Clinical Trial Material Product
    Table 55. Marken Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 56. Marken Recent Development
    Table 57. Catalent Company Detail
    Table 58. Catalent Business Overview
    Table 59. Catalent Clinical Trial Material Product
    Table 60. Catalent Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 61. Catalent Recent Development
    Table 62. Eurofins Scientific Company Detail
    Table 63. Eurofins Scientific Business Overview
    Table 64. Eurofins Scientific Clinical Trial Material Product
    Table 65. Eurofins Scientific Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 66. Eurofins Scientific Recent Development
    Table 67. Biocair Company Detail
    Table 68. Biocair Business Overview
    Table 69. Biocair Clinical Trial Material Product
    Table 70. Biocair Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 71. Biocair Recent Development
    Table 72. Almac Group Company Detail
    Table 73. Almac Group Business Overview
    Table 74. Almac Group Clinical Trial Material Product
    Table 75. Almac Group Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 76. Almac Group Recent Development
    Table 77. Piramal Pharma Solutions Company Detail
    Table 78. Piramal Pharma Solutions Business Overview
    Table 79. Piramal Pharma Solutions Clinical Trial Material Product
    Table 80. Piramal Pharma Solutions Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 81. Piramal Pharma Solutions Recent Development
    Table 82. Parexel Company Detail
    Table 83. Parexel Business Overview
    Table 84. Parexel Clinical Trial Material Product
    Table 85. Parexel Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 86. Parexel Recent Development
    Table 87. PRA Health Sciences Company Detail
    Table 88. PRA Health Sciences Business Overview
    Table 89. PRA Health Sciences Clinical Trial Material Product
    Table 90. PRA Health Sciences Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 91. PRA Health Sciences Recent Development
    Table 92. PCI Pharma Services Company Detail
    Table 93. PCI Pharma Services Business Overview
    Table 94. PCI Pharma Services Clinical Trial Material Product
    Table 95. PCI Pharma Services Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 96. PCI Pharma Services Recent Development
    Table 97. Capsugel Company Detail
    Table 98. Capsugel Business Overview
    Table 99. Capsugel Clinical Trial Material Product
    Table 100. Capsugel Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 101. Capsugel Recent Development
    Table 102. OCT Group Company Detail
    Table 103. OCT Group Business Overview
    Table 104. OCT Group Clinical Trial Material Product
    Table 105. OCT Group Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 106. OCT Group Recent Development
    Table 107. Acnos Pharma Company Detail
    Table 108. Acnos Pharma Business Overview
    Table 109. Acnos Pharma Clinical Trial Material Product
    Table 110. Acnos Pharma Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 111. Acnos Pharma Recent Development
    Table 112. KLIFO Company Detail
    Table 113. KLIFO Business Overview
    Table 114. KLIFO Clinical Trial Material Product
    Table 115. KLIFO Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 116. KLIFO Recent Development
    Table 117. Ancillare, LP Company Detail
    Table 118. Ancillare, LP Business Overview
    Table 119. Ancillare, LP Clinical Trial Material Product
    Table 120. Ancillare, LP Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 121. Ancillare, LP Recent Development
    Table 122. ADAllen Pharma Company Detail
    Table 123. ADAllen Pharma Business Overview
    Table 124. ADAllen Pharma Clinical Trial Material Product
    Table 125. ADAllen Pharma Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 126. ADAllen Pharma Recent Development
    Table 127. Recipharm Company Detail
    Table 128. Recipharm Business Overview
    Table 129. Recipharm Clinical Trial Material Product
    Table 130. Recipharm Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 131. Recipharm Recent Development
    Table 132. Movianto Company Detail
    Table 133. Movianto Business Overview
    Table 134. Movianto Clinical Trial Material Product
    Table 135. Movianto Revenue in Clinical Trial Material Business (2019-2024) & (US$ Million)
    Table 136. Movianto Recent Development
    Table 137. Research Programs/Design for This Report
    Table 138. Key Data Information from Secondary Sources
    Table 139. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Clinical Trial Material Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Clinical Trial Material Market Share by Type: 2023 VS 2030
    Figure 3. Small-molecules Features
    Figure 4. Biologic Drugs Features
    Figure 5. Medical Devices Features
    Figure 6. Global Clinical Trial Material Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Clinical Trial Material Market Share by Application: 2023 VS 2030
    Figure 8. Oncology Case Studies
    Figure 9. CNS Case Studies
    Figure 10. Cardiovascular Diseases Case Studies
    Figure 11. Digestive Disorders Case Studies
    Figure 12. Immunology Case Studies
    Figure 13. Blood Disorders Case Studies
    Figure 14. Other Case Studies
    Figure 15. Clinical Trial Material Report Years Considered
    Figure 16. Global Clinical Trial Material Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 17. Global Clinical Trial Material Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Clinical Trial Material Market Share by Region: 2023 VS 2030
    Figure 19. Global Clinical Trial Material Market Share by Players in 2023
    Figure 20. Global Top Clinical Trial Material Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Material as of 2023)
    Figure 21. The Top 10 and 5 Players Market Share by Clinical Trial Material Revenue in 2023
    Figure 22. North America Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. North America Clinical Trial Material Market Share by Country (2019-2030)
    Figure 24. United States Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Clinical Trial Material Market Share by Country (2019-2030)
    Figure 28. Germany Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Asia-Pacific Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Asia-Pacific Clinical Trial Material Market Share by Region (2019-2030)
    Figure 36. China Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Japan Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. South Korea Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Southeast Asia Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. India Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Australia Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Latin America Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Latin America Clinical Trial Material Market Share by Country (2019-2030)
    Figure 44. Mexico Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Brazil Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Clinical Trial Material Market Share by Country (2019-2030)
    Figure 48. Turkey Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Saudi Arabia Clinical Trial Material Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 51. Marken Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 52. Catalent Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 53. Eurofins Scientific Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 54. Biocair Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 55. Almac Group Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 56. Piramal Pharma Solutions Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 57. Parexel Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 58. PRA Health Sciences Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 59. PCI Pharma Services Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 60. Capsugel Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 61. OCT Group Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 62. Acnos Pharma Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 63. KLIFO Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 64. Ancillare, LP Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 65. ADAllen Pharma Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 66. Recipharm Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 67. Movianto Revenue Growth Rate in Clinical Trial Material Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools